| Date | Title | Description |
| 07.12.2024 | Qi Biodesign: A New Dawn in Genome Editing | In the world of biotechnology, Qi Biodesign is making waves. This Beijing-based company has just completed a Series A funding round, raising a total of $75 million. This funding is a beacon of hope for the future of genome editing. It’s a t... |
| 06.12.2024 | Qi Biodesign Completes $75M in Total Funding | Qi Biodesign, a Beijing, China-based biotechnology company pioneering next-generation genome editing technologies, completed its Series A funding round.
The Series A round was led by the Beijing Medical and Health Care Industry Investment F... |
| 06.12.2024 | Qi Biodesign Completes $75 Million in Total Funding to Drive Genome Editing Innovations | BEIJING, Dec. 6, 2024 /PRNewswire/ -- Qi Biodesign, a biotechnology company pioneering next-generation genome editing technologies, announced the completion of its Series A funding round. The company has now raised a total of $75 million ac... |
| - | Qihe Biotech | “齐禾官官 齐” |
